{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:30:09Z","timestamp":1791613809465,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.tjog.2019.07.005","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T18:44:58Z","timestamp":1568832298000},"page":"604-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome"],"prefix":"10.1016","volume":"58","author":[{"given":"Yu-Jung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nae-Fang","family":"Twu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tjog.2019.07.005_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol \u2013 J Eur Soc Ther Radiol Oncol"},{"issue":"1","key":"10.1016\/j.tjog.2019.07.005_bib2","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"Ca - Cancer J Clin"},{"issue":"21","key":"10.1016\/j.tjog.2019.07.005_bib3","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.tjog.2019.07.005_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0360-3016(92)90786-H","article-title":"Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system","volume":"22","author":"Grigsby","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9213","key":"10.1016\/j.tjog.2019.07.005_bib5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tjog.2019.07.005_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A\u00a0phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"9717","key":"10.1016\/j.tjog.2019.07.005_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tjog.2019.07.005_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0029-7844(97)00286-X","article-title":"Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome","volume":"90","author":"Sood","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.tjog.2019.07.005_bib9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1067\/mob.2000.106251","article-title":"Preoperative CA 125 in endometrial cancer: is it useful?","volume":"182","author":"Dotters","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.tjog.2019.07.005_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2010.04.018","article-title":"Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study","volume":"118","author":"Kim","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.tjog.2019.07.005_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/IGC.0000000000001229","article-title":"Prognostic significance of lymphovascular space invasion in the absence of lymph node metastases in early-stage endometrial cancer","volume":"28","author":"Cusano","year":"2018","journal-title":"Int J Gynecol Cancer \u2013 Off J Int Gynecol Canc Soc"},{"issue":"4","key":"10.1016\/j.tjog.2019.07.005_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.12.025","article-title":"Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma","volume":"210","author":"Benedetti Panici","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.tjog.2019.07.005_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1115::AID-CNCR17>3.0.CO;2-4","article-title":"Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage\u2013a Gynecologic Oncology Group study","volume":"77","author":"Zaino","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.tjog.2019.07.005_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1028-4559(09)60064-4","article-title":"Is adjuvant radiotherapy effective in intermediate-risk surgical stage I endometrial cancer?","volume":"43","author":"Yu","year":"2004","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.tjog.2019.07.005_bib15","first-page":"87","article-title":"Prognostic factors affecting the outcome of endometrial cancer","volume":"13","author":"Pi","year":"2006","journal-title":"\u653e\u5c04\u6cbb\u7642\u8207\u816b\u7624\u5b78"},{"issue":"4","key":"10.1016\/j.tjog.2019.07.005_bib16","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.tjog.2019.07.005_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ygyno.2005.03.008","article-title":"Predictors of vaginal relapse in stage I endometrial cancer","volume":"97","author":"Mariani","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.tjog.2019.07.005_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/00016340701876163","article-title":"Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer","volume":"87","author":"Zusterzeel","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.tjog.2019.07.005_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.tjog.2019.07.005_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000131270","article-title":"Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer","volume":"31","author":"Kim","year":"2008","journal-title":"Onkologie"},{"issue":"11","key":"10.1016\/j.tjog.2019.07.005_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/aogs.12235","article-title":"HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)","volume":"92","author":"Antonsen","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.tjog.2019.07.005_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9378(86)90358-3","article-title":"125: a useful marker in endometrial carcinoma","volume":"155","author":"Duk","year":"1986","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.tjog.2019.07.005_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int J Gynecol Cancer \u2013 Off J Int Gynecol Canc Soc"},{"issue":"11","key":"10.1016\/j.tjog.2019.07.005_bib24","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/PAS.0b013e318299f2ab","article-title":"The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma","volume":"37","author":"Euscher","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"Suppl.\u00a08","key":"10.1016\/j.tjog.2019.07.005_bib25","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.tjog.2019.07.005_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0360-3016(90)90093-Y","article-title":"Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors","volume":"18","author":"Meerwaldt","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.tjog.2019.07.005_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3802\/jgo.2012.23.4.257","article-title":"Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma","volume":"23","author":"Bahng","year":"2012","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.tjog.2019.07.005_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455919301603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455919301603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:16:41Z","timestamp":1760897801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455919301603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1028455919301603"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2019.07.005","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2019.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}